Sen. John Hoeven sold Bristol-Myers Squibb Company (BMY)
Sen. John Hoeven (R-ND) · $50K–$100K · traded Jan 20, 2017
- Transaction
- Sold (full)
- Amount
- $50K–$100K
- Owner
- The member
- Traded
- Jan 20, 2017
- Disclosed
- Jan 25, 2017
- Days to disclose
- 5
- Asset type
- Stock
- As filed
- Bristol-Myers Squibb Company
- Industry
- Drug Manufacturers - General · Healthcare
Other trades in this filing
- Jan 25, 2017$50K–$100K
$50K–$100K · Traded Jan 25, 2017 · disclosed Jan 25, 2017
Got $3K from the company’s PAC - Jan 25, 2017$50K–$100K
Bought Willis Towers Watson Public Limited Company WTW
$50K–$100K · Traded Jan 24, 2017 · disclosed Jan 25, 2017
- Jan 25, 2017$50K–$100K
$50K–$100K · Traded Jan 23, 2017 · disclosed Jan 25, 2017
- Jan 25, 2017$100K–$250K
$100K–$250K · Traded Jan 20, 2017 · disclosed Jan 25, 2017
- Jan 25, 2017$50K–$100K
Bought Verizon Communications VZ
$50K–$100K · Traded Jan 20, 2017 · disclosed Jan 25, 2017
Got $10K from the company’s PAC - Jan 25, 2017$100K–$250K
Sold (full) Johnson & Johnson JNJ
$100K–$250K · Traded Jan 20, 2017 · disclosed Jan 25, 2017
- Jan 25, 2017$50K–$100K
$50K–$100K · Traded Jan 20, 2017 · disclosed Jan 25, 2017
Got $2K from the company’s PAC - Jan 25, 2017$50K–$100K
$50K–$100K · Traded Jan 20, 2017 · disclosed Jan 25, 2017
- Jan 25, 2017$100K–$250K
Bought The Procter & Gamble Company PG
$100K–$250K · Traded Jan 20, 2017 · disclosed Jan 25, 2017
- Jan 25, 2017$100K–$250K
Bought The Coca-Cola Company KO
$100K–$250K · Traded Jan 20, 2017 · disclosed Jan 25, 2017
Got $4K from the company’s PAC - Jan 25, 2017$100K–$250K
$100K–$250K · Traded Jan 20, 2017 · disclosed Jan 25, 2017
Got $3K from the company’s PAC - Jan 25, 2017$50K–$100K
$50K–$100K · Traded Jan 20, 2017 · disclosed Jan 25, 2017
Got $5K from the company’s PAC - Jan 25, 2017$100K–$250K
$100K–$250K · Traded Jan 20, 2017 · disclosed Jan 25, 2017
- Jan 25, 2017$50K–$100K
$50K–$100K · Traded Jan 20, 2017 · disclosed Jan 25, 2017
- Jan 25, 2017$50K–$100K
$50K–$100K · Traded Jan 12, 2017 · disclosed Jan 25, 2017
Recent Congress trades in BMY
- Nov 5, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
Bought Bristol-Myers Squibb Company BMY
$1K–$15K · Traded Oct 13, 2026 · disclosed Nov 5, 2026 · Spouse
- Nov 5, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
Sold Bristol-Myers Squibb Company BMY
$1K–$15K · Traded Oct 7, 2026 · disclosed Nov 5, 2026 · Spouse
- Jul 21, 2026$1K–$15K
Sen. Alan Armstrong (R-OK)
Bought Bristol-Myers Squibb Company BMY
$1K–$15K · Traded Mar 27, 2026 · disclosed Jul 21, 2026 · filed 116 days later
Committee overlap: HELP - Jun 11, 2026$15K–$50K
Rep. Mike Kelly (R-PA-16)
Sold Bristol-Myers Squibb Company BMY
$15K–$50K · Traded May 7, 2026 · disclosed Jun 11, 2026 · Spouse
Got $3K from the company’s PAC - Feb 6, 2026$15K–$50K
Rep. Ro Khanna (D-CA-17)
Sold Bristol-Myers Squibb Company BMY
$15K–$50K · Traded Jan 29, 2026 · disclosed Feb 6, 2026 · Spouse
- Jan 15, 2026$1K–$15K
Rep. Julie Johnson (D-TX-32)
Sold Bristol-Myers Squibb Company BMY
$1K–$15K · Traded Dec 18, 2025 · disclosed Jan 15, 2026 · Joint
- Jan 13, 2026$1K–$15K
Rep. Julia Letlow (R-LA-5)
Sold Bristol-Myers Squibb Company BMY
$1K–$15K · Traded Apr 28, 2025 · disclosed Jan 13, 2026 · filed 260 days later
Got $2K from the company’s PAC - Jan 13, 2026$1K–$15K
Rep. Julia Letlow (R-LA-5)
Bought Bristol-Myers Squibb Company BMY
$1K–$15K · Traded Oct 23, 2024 · disclosed Jan 13, 2026 · filed 447 days later
Got $2K from the company’s PAC
Company context for BMY
Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.
BMY: 10-Q financial filing
Filed 10-Q for an event or period dated 2026-09-30. Read the company report for its disclosures.
1 congressional household disclosed purchases in the past 90 days. See the trades
BMY: Financial results · Company disclosure
Filed 8-K for an event or period dated 2026-10-29. Financial results; Company disclosure.
1 congressional household disclosed purchases in the past 90 days. See the trades
BMY: third_quarter 2026 lobbying report
Access to prescription drugs. Policies related to 340B. Drug Pricing reform/implementation. Food is Medicine initiatives. Issues related to the budget and appropriations process
Public: Oct 20, 2026, 11:15 PM EDTOriginal source ↗1 congressional household disclosed purchases in the past 90 days. See the trades
From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.